1 / 3

Vasomotor symptoms (Hot flashes/Night sweats) Infographics

Vasomotor symptoms (Hot flashes/Night sweats) Market Insight, Epidemiology And Market Forecast<br><br>Read More- https://www.delveinsight.com/infographics/vasomotor-symptoms-market?utm_source=marketing&utm_medium=promotion&utm_campaign=infographic

yashb
Download Presentation

Vasomotor symptoms (Hot flashes/Night sweats) Infographics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vasomotor Symptoms (VMS) are episodes of profuse heat accompanied by sweating and flushing, which are experienced majorly around the head, neck, chest, and upper back. Vasomotor symptoms are often accompanied by hot flashes and night sweats and are often considered as the cardinal symptoms of menopause. The VMS may also include heart palpitations and changes in blood pressure. Vasomotor Symptoms Epidemiology Segmentation in the 7MM Total Prevalent Cases of Vasomotor Symptoms Total Age-specific Cases of Vasomotor Symptoms Total Treated Cases of Vasomotor Symptoms Total Severity-specific Cases of Vasomotor Symptoms Vasomotor Symptoms Epidemiological Insights Observed in the 7MM (2021) The total prevalent cases of Vasomotor Symptoms in 7MM were estimated to be 136.02 million. The Age-Specific prevalent cases of Vasomotor Symptoms in the 7MM were found to be 18.45 million in population aged between 40-44 years, 24.23 million in people with 45-49 years of age, 26.15 million people of the age 50-54 years, 32.16 million of the population between 55- 59 years and 37.23 million people of the age 60-65 years. Vasomotor Symptoms Market Insight The market size of Vasomotor Symptoms in the 7MM was found to be approximately USD 15,026 million in the year 2021. Vasomotor Symptoms Market Drivers Increasing awareness Rising emerging therapies Novel mechanism of action Increasing initiatives for R&D Vasomotor Symptoms Market Barriers Generic nature of the market Limited understanding of the pathophysiology Lack of robust developmental pipeline Lack of trained and professional physicians

  2. Vasomotor Symptoms Emerging Drugs The emerging drugs in the Vasomotor Symptoms market are Donesta (E4, Estetrol) Elinzanetant (BAY-3427080, NT 814) Fezolinetant (ESN-364) MNGX-100 (Filgrastim, G-CSF) Elismetrep (MT-8554) Q-122 (MSX-122), and many others Vasomotor Symptoms Key Players The key players working in the Vasomotor Symptoms market are Estetra Mithra Pharmaceuticals Bayer Nerre Therapeutics Ltd. Astellas Pharma MenoGeniX Mitsubishi Tanabe Pharma QUE Oncology, and several others Also, read- Vasomotor symptoms (Hot flashes/Night sweats) | Vasomotor symptoms (Hot flashes/Night sweats) Infographics | Vasomotor symptoms (Hot flashes/Night sweats) Market

More Related